Detalles de la búsqueda
1.
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Gastroenterology
; 156(8): 2242-2253.e4, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30836094
2.
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
Oncotarget
; 7(17): 24172-8, 2016 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26992220
3.
Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Oncotarget
; 7(9): 10547-56, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26859683
4.
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.
Clin Cancer Res
; 22(13): 3281-5, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26933124
5.
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
Clin Cancer Res
; 21(16): 3631-9, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25567908
6.
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI.
Lung Cancer
; 89(3): 357-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26187428
7.
Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib.
J Thorac Oncol
; 9(12): 1821-5, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25393796
Resultados
1 -
7
de 7
1
Próxima >
>>